Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SUNPHARMA and BSE: 524715 (ISIN INE044A01036).
It has a market capitalisation of ₹4.18 lakh crore, a last close of ₹1,743 on 2026-10-19, a one-year return of 3.8%.
Valuation: a price-to-earnings ratio of 34.57x, a price-to-book ratio of 5.00x, a dividend yield of 0.9%.
Profitability: return on equity of 14.7%, return on capital employed of 19.3%, an operating margin of 29.8%.
Growth: sales growth of 10.0% a year over three years, net profit growth of 10.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.05x, promoter holding of 52.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 4.18 L Cr |
| Last close | ₹1,743 |
| P/E (TTM) | 34.57x |
| P/B | 5.00x |
| Dividend yield | 0.9% |
| ROE (FY) | 14.7% |
| ROCE (FY) | 19.3% |
| Operating margin (TTM) | 29.8% |
| Sales growth, 3-year CAGR | 10.0% |
| Profit growth, 3-year CAGR | 10.6% |
| Debt / equity | 0.05x |
| Promoter holding | 52.7% |
| 1-year return | 3.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means